Bioanalysis Zone sat down with Afshin Safavi, Founder and Chief Scientific Officer of BioAgilytix, at the recent Reid Bioanalytical Forum and discussed the challenges faced when running biomarker studies, whether the use of biomarkers in preclinical and clinical studies will continue and more. Click the link below to watch the full interview.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Platforms
Services